Clinical Trial Update: Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?

View source ↗

Summary

An update on a clinical study investigating the gut microbiome as a potential personalized therapeutic target for coronary artery disease / coronary atheroscler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Atherosclerosis

Snippet

Sponsor: Rabin Medical Center | Conditions: Coronary (Artery) Disease | Status: UNKNOWN